Combating substandard and falsified medicines in China: policy barriers and the role of pharmaceutical track-and-trace systems
Substandard and falsified medicines (SF medicines) pose a severe threat to population health and safety. China has a large proportion of SF medicines, imposing a heavy economic burden and exacerbating inequities in access to quality medications. Addressing this issue urgently is critical to safeguar...
Saved in:
| Main Author: | Tangsiwei Xin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Critical Public Health |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09581596.2025.2513645 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stakeholders’ perspectives and experiences with the quality of essential medicines in primary healthcare facilities in Ghana: a qualitative study
by: Irene A. Kretchy, et al.
Published: (2025-04-01) -
Quality of antidiabetic medicines in 13 sub-Saharan African countries: a cross-sectional surveyResearch in context
by: Marie Antignac, et al.
Published: (2025-09-01) -
Evaluation of implementing drug checking services for anabolic androgenic steroids in Switzerland: a pilot study
by: Raphael Magnolini, et al.
Published: (2025-06-01) -
Lexical and functional substandard in forensic linguistics
by: Z. I. Mineeva
Published: (2025-03-01) -
Assessing ethical practices among community pharmacists in Nigeria: prevalence, drivers, challenges, and implications—a mixed methods study
by: Olanrewaju Olamide Popoola, et al.
Published: (2025-05-01)